Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3915320rdf:typepubmed:Citationlld:pubmed
pubmed-article:3915320lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3915320lifeskim:mentionsumls-concept:C0033497lld:lifeskim
pubmed-article:3915320lifeskim:mentionsumls-concept:C0178665lld:lifeskim
pubmed-article:3915320lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:3915320pubmed:issue2lld:pubmed
pubmed-article:3915320pubmed:dateCreated1986-7-25lld:pubmed
pubmed-article:3915320pubmed:abstractTextChronic diuretic therapy in hypertensive patients may be associated with a reversible deterioration in glucose tolerance. There is evidence to suggest that beta-blocker monotherapy may cause a deterioration in glucose tolerance in patients with non-insulin-dependent diabetes mellitus but little information about the effects of chronic beta-blocker treatment in hypertensive patients with normal glucose metabolism. A prospective evaluation of the effects of propranolol monotherapy on glucose tolerance was performed in 13 nondiabetic hypertensive patients. One patient developed diabetes mellitus after 1 month of treatment. Of 11 patients, 4 had a 30% or greater increase in fasting glucose after 1 year of therapy and a significant increase in fasting, and 2-hour postglucose-load venous plasma glucose occurred in the 9 patients completing 18 months of treatment. Although the biologic significance of these changes is questionable, the development of hyperglycemia in a patient receiving beta blockers could represent a side effect of drug therapy.lld:pubmed
pubmed-article:3915320pubmed:languageenglld:pubmed
pubmed-article:3915320pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3915320pubmed:citationSubsetIMlld:pubmed
pubmed-article:3915320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3915320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3915320pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3915320pubmed:statusMEDLINElld:pubmed
pubmed-article:3915320pubmed:monthJunlld:pubmed
pubmed-article:3915320pubmed:issn0748-450Xlld:pubmed
pubmed-article:3915320pubmed:authorpubmed-author:GiffordR...lld:pubmed
pubmed-article:3915320pubmed:authorpubmed-author:VidtD GDGlld:pubmed
pubmed-article:3915320pubmed:authorpubmed-author:MohlerHHlld:pubmed
pubmed-article:3915320pubmed:authorpubmed-author:CressmanM DMDlld:pubmed
pubmed-article:3915320pubmed:issnTypePrintlld:pubmed
pubmed-article:3915320pubmed:volume1lld:pubmed
pubmed-article:3915320pubmed:ownerNLMlld:pubmed
pubmed-article:3915320pubmed:authorsCompleteYlld:pubmed
pubmed-article:3915320pubmed:pagination138-44lld:pubmed
pubmed-article:3915320pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:meshHeadingpubmed-meshheading:3915320-...lld:pubmed
pubmed-article:3915320pubmed:year1985lld:pubmed
pubmed-article:3915320pubmed:articleTitleGlucose tolerance during chronic propranolol treatment.lld:pubmed
pubmed-article:3915320pubmed:publicationTypeJournal Articlelld:pubmed